Panacea Biotec Wins Lucrative Polio Vaccine Contract

Panacea Biotec Ltd has secured a significant contract to supply bivalent oral polio vaccines worth Rs 127.2 crore to the Central Medical Services Society under the Ministry of Health and Family Welfare. The supply will be executed in multiple batches over 90 to 480 days from the acceptance date.


Devdiscourse News Desk | New Delhi | Updated: 09-10-2025 13:08 IST | Created: 09-10-2025 13:08 IST
Panacea Biotec Wins Lucrative Polio Vaccine Contract
This image is AI-generated and does not depict any real-life event or location. It is a fictional representation created for illustrative purposes only.
  • Country:
  • India

Panacea Biotec Ltd announced on Thursday that it will be providing bivalent oral polio vaccines valued at Rs 127.2 crore to the Central Medical Services Society, which operates under the Ministry of Health and Family Welfare.

This development follows the acceptance of the company's proposal by the CMSS, as confirmed in a Letter of Acceptance (LOA) dated October 8, 2025.

The agreed terms detail that Panacea Biotec will deliver the vaccines in several installments, over a span ranging from 90 to 480 days from the issuance date of the LOA.

(With inputs from agencies.)

Give Feedback